ERBB2 and ovarian carcinoma: The obtained results are promising for further development of Au@193m,195mPt nanoparticles conjugates as a novel Auger electron-emitting radiation nanomedicine for the treatment of HER2-positive breast and ovarian cancer and HCC therapy.